ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1550457
This article is part of the Research TopicDrug Repurposing to Fight Resistant Fungal Species: Recent Developments as Novel Therapeutic StrategiesView all 9 articles
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
Provisionally accepted- 1Molecular Small Animal Imaging Centre, Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium
- 2Department of Respiratory Medicine, Ghent University Hospital, Ghent, East Flanders, Belgium
- 3Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, East Flanders, Belgium
- 4Centre of Microbial and Plant Genetics, Department of Microbial and Molecular Systems, Faculty of Bioscience Engineering, KU Leuven, Heverlee, Belgium
- 5Plant Institute, KU Leuven, Leuven, Belgium
- 6Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
- 7National Reference Center for Mycosis, Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Solid organ transplant recipients on immunosuppressants such as tacrolimus are at increased risk of developing pulmonary aspergillosis, a severe to deadly complication with limited treatment options, especially against azole-resistant strains. This study investigates the antifungal interaction between posaconazole and tacrolimus, prompted by a case where a liver transplant recipient on tacrolimus experienced unexpected eradication of chronic Aspergillus fumigatus colonization following posaconazole prophylaxis. Methods: We compared the combined antifungal activity of posaconazole and tacrolimus against azole-sensitive and resistant A. fumigatus in vitro against planktonic isolates and biofilm formation and in vivo in Galleria mellonella larvae, to evaluate the potential benefit over posaconazole monotherapy.Results: The posaconazole-tacrolimus combination demonstrated a 4-fold increase in efficacy against azole-resistant isolates and a 30-fold increase against an azole-sensitive strain, in contrast to voriconazole. Moreover, this combination enhanced antifungal activity by 4- to 15-fold against biofilm formation of azole-sensitive strains, though no synergy was observed against azole-resistant biofilms. In vivo studies in Galleria mellonella confirmed a 2- to 7-fold decrease in fungal burden of both azole-sensitive and azole-resistant strains when combining posaconazole with tacrolimus, relative to posaconazole alone. Conclusion: In vitro and in vivo findings confirm that posaconazole may offer therapeutic benefits for treating A. fumigatus infections in patients receiving tacrolimus. These results warrant further confirmation in mice and exploration of their clinical implications.
Keywords: Posaconazole, Tacrolimus, FK506, Transplantation, Synergy, Aspergillus fumigatus, Azole-resistance, Biofilm
Received: 23 Dec 2024; Accepted: 24 Mar 2025.
Copyright: © 2025 Vanhoffelen, Van Win, Van Braeckel, Reséndiz-Sharpe, Cammue, Lagrou, Thevissen and Vande Velde. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Greetje Vande Velde, Molecular Small Animal Imaging Centre, Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, 3000, Belgium
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.